Beat the Market the Zacks Way: Ryanair, Monster Beverage, Ulta Beauty in Focus

Stock Information for Microbot Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Microbot Medical Inc.

Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
Microbot Medical Selected for Preliminary Inclusion to Russell Microcap® Index
Microbot Medical® Bolsters Commercial Leadership Team with the Addition of Experienced Healthcare Officers
Microbot Medical® Shares Results from Its Pivotal Clinical Trial, Achieving 100% Robotic Navigation Success for the LIBERTY® Endovascular Robotic System
REMINDER: Microbot Medical Announces Data from the Company's ACCESS-PVI trial will be Presented via Podium Presentation at Society of Interventional Radiology Annual Meeting
Microbot Medical Appoints Seasoned Endovascular Sales Executive to Lead its U.S. Sales Activities for LIBERTY® Endovascular Robotic System
Robotic Telesurgery Data from Collaboration with Corewell Health(TM) Accepted for Presentation at the Cardiovascular Research Technologies Annual Meeting

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.